Your browser doesn't support javascript.
loading
The SWI/SNF subunit SMARCD3 regulates cell cycle progression and predicts survival outcome in ER+ breast cancer.
Tropée, Romain; de la Peña Avalos, Bárbara; Gough, Madeline; Snell, Cameron; Duijf, Pascal H G; Dray, Eloïse.
Affiliation
  • Tropée R; IHBI, Queensland University of Technology, Brisbane, QLD, Australia.
  • de la Peña Avalos B; IHBI, Queensland University of Technology, Brisbane, QLD, Australia.
  • Gough M; Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Snell C; Mays Cancer Center, UT Health San Antonio MD Anderson, San Antonio, TX, USA.
  • Duijf PHG; Cancer Pathology Research Group, Mater Research Institute, The University of Queensland, Translational Research Institute, 37 Kent St, Woolloongabba, QLD, 4102, Australia.
  • Dray E; Mater Pathology, Mater Hospital Brisbane, Mater Misericordiae Limited, South Brisbane, QLD, 4101, Australia.
Breast Cancer Res Treat ; 185(3): 601-614, 2021 Feb.
Article in En | MEDLINE | ID: mdl-33180234
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Transcription Factors / Breast Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2021 Type: Article Affiliation country: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Transcription Factors / Breast Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2021 Type: Article Affiliation country: Australia